Being diagnosed with advanced metastatic pancreatic cancer was a grim experience for Steve Price. But thanks to his doctors at Weill Cornell Medicine and NewYork-Presbyterian, state-of-the-art interventional radiology allowed him to receive chemotherapy immediately after biopsy, shrinking his tumors dramatically. Then, a precision medicine clinical trial revealed that Price had a mutation in the BRCA1 gene, normally associated with breast cancer. By examining his unique genetic profile, Price’s medical team was able to determine that a new therapy targeting the mutation could give him his life back.
Interested in learning more about our team of doctors, their patients and how our research is changing lives? Like and subscribe to make sure you never miss out on any of our upcoming videos.
Steve’s Care Team
Dr. Allyson Ocean, please visit [ Ссылка ]
Dr. Olivier Elemento, please visit [ Ссылка ]
Sandra and Edward Meyer Cancer Center please visit [ Ссылка ]
The Englander Institute for Precision Medicine please visit [ Ссылка ]
Dr. Kyungmouk Steve Lee, please visit [ Ссылка ]
Dr. Robert Min, please visit [ Ссылка ]
Interventional Radiology please visit [ Ссылка ]
To learn more about Weill Cornell Medicine patient care please visit here. [ Ссылка ] To learn about education and research at Weill Cornell Medicine visit here. [ Ссылка ]
Keep up with our social posts on
Facebook [ Ссылка ]
Twitter [ Ссылка ]
Instagram [ Ссылка ]
LinkedIn [ Ссылка ]
